Neuroleptic malignant syndrome: A case report

Basit Öğe Kaydı
dc.authorscopusid39062344400
dc.authorscopusid55245763100
dc.authorscopusid53063153200
dc.authorscopusid53063557000
dc.authorscopusid24175702100
dc.authorscopusid55358223900
dc.authorscopusid55898697800
dc.contributor.authorTekelio?lu, Ümit Yaşar
dc.contributor.authorYildiz, Isa
dc.contributor.authorBayir, Hakan
dc.contributor.authorDemirhan, Abdullah
dc.contributor.authorAkkaya, Akcan
dc.contributor.authorDuran, Arif
dc.contributor.authorKoço?lu, Hasan
dc.date.accessioned2024-09-25T19:45:18Z
dc.date.available2024-09-25T19:45:18Z
dc.date.issued2012
dc.departmentAbant İzzet Baysal Üniversitesien_US
dc.description.abstractNeuroleptic Malignant Syndrome (NMS) is usually seen in patients who use antipsychotic drugs and has a high mortality rate. It is a life-threatening condition associated with dopaminergic blockage. Symptoms include high fever, diaphoresis, unstable blood pressure, unconsciousness, muscular rigidity, and autonomic dysfunction. The 46-year-old male patient who had a history of 10 years of klozapin use due to schizophrenia applied to the emergency service with unconscionsness, speech disorder and high fever. Having a history of irregular use of medicine in the recent past, the patient was restarted with klozapin as his symptoms increased. During the neurological examination, he had impaired consciousness and muscular rigidity. The laboratory analysis revealed the leukocyte 13.800/mm3, AST: 2.067 U/L, ALT: 295 U/L, LDH: 5.709 U/L, CK-MB: 1.189 U/L, CK: 123.889 U/L. He was diagnosed as NMS. By presenting this case, we aim to discuss the approaches to NMS and treatment modalities of NMS in light of the literature.en_US
dc.identifier.doi10.5152/TJAR.2012.016
dc.identifier.endpage331en_US
dc.identifier.issn1305-614X
dc.identifier.issue6en_US
dc.identifier.scopus2-s2.0-84886281952en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage329en_US
dc.identifier.urihttps://doi.org/10.5152/TJAR.2012.016
dc.identifier.urihttps://hdl.handle.net/20.500.12491/12962
dc.identifier.volume40en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.relation.ispartofTurk Anesteziyoloji ve Reanimasyon Dernegi Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzYK_20240925en_US
dc.subjectAntipsychoticen_US
dc.subjectIntensive careen_US
dc.subjectNeuroleptic malignant syndromeen_US
dc.titleNeuroleptic malignant syndrome: A case reporten_US
dc.title.alternativeNöroleptik malign sendrom: Olgu sunumu]en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu